Quantitative multiplexed at-home diagnostic device for micronutrient deficiencies
William Oak Diagnostics offers a quantitative, multiplexed at-home diagnostic device for detecting micronutrient deficiencies. Using microfluidics and lateral flow technology, it tests vitamin D, B12, folate, iron, and hemoglobin from a single drop of blood.
Overview
William Oak Diagnostics has developed an innovative at-home diagnostic device that quantitatively tests for key micronutrient deficiencies using a single drop of blood. This device utilizes advanced microfluidics and lateral flow technology to conduct parallel tests for vitamin D, B12, folate, iron, and total hemoglobin. Coupled with a smartphone app, the device provides quantitative results, aiding in decision-making and integration with healthcare records. This solution enables at-home monitoring, personalized supplementation, and referrals to healthcare specialists as needed.
Technical specifications
- Microfluidics and lateral flow technology: Allows for simultaneous testing of multiple micronutrients.
- Smartphone app integration: Converts test results into quantitative data (ng/ml) for easy interpretation and healthcare record integration.
- User-friendly design: Suitable for at-home use by individuals, providing immediate insights into micronutrient levels.
- Assay accuracy: Benchmarked using patient serum samples, demonstrating reliability and precision in results.
Technology readiness level
This technology is at TRL 3, with ongoing development under design control to achieve regulatory compliance. The current focus is on full product development and optimization, with a design freeze expected in 2026 and regulatory approval anticipated by early 2027.
About William Oak Diagnostics Ltd
William Oak Diagnostics is a medical diagnostic company developing innovative, point-of-care testing technology to detect micronutrient deficiencies. Its flagship solution is a microfluidic device designed to simplify sample collection and analysis, allowing for accurate testing outside traditional laboratory environments. By integrating capillary blood collection with diagnostic assays, the company's technology aims to replace invasive and costly blood draws with a convenient, button-operated mechanism. This approach enables broader access to micronutrient monitoring for healthcare professionals and patients alike, potentially supporting better clinical outcomes through faster identification of deficiencies.
The company's work is driven by a mission to improve public health by addressing nutritional gaps, particularly in vulnerable populations such as newborns, children, and the elderly. Founded in 2023 following a personal loss to vitamin K deficiency, the organization focuses on making diagnostic tools for preventable conditions simple, accessible, and actionable. With support from research funding and strategic locations at pioneering clinical research sites, William Oak Diagnostics is actively scaling its development of point-of-care and B2B products to streamline patient care, reduce unnecessary testing burdens on healthcare systems, and ensure timely interventions for those at risk.
delivered to your inbox.